A 73-year-old with severe COPD is on LABA/LAMA/ICS and continues frequent exacerbations with chronic bronchitis phenotype. Eosinophils 350/µL. Which a...

Question

A 73-year-old with severe COPD is on LABA/LAMA/ICS and continues frequent exacerbations with chronic bronchitis phenotype. Eosinophils 350/µL. Which add-on is evidence-supported?

Accepted Answer

Dupilumab

Answer

Omalizumab

Answer

Reslizumab

Answer

Tezepelumab

Answer

No biologic therapy exists

us-abim MCQ (SBA): COPD-Advanced Therapies

A 73-year-old with severe COPD is on LABA/LAMA/ICS and continues frequent exacerbations with chronic bronchitis phenotype. Eosinophils 350/µL. Which add-on is evidence-supported?